Results 211 to 220 of about 929,659 (335)

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang, Shenglan Li, Liang Wang, Qianxue Chen, Weiguo Hu, Ting Lei, Ying Mao, Jing Zhang, Xiaojun Xiang, Qiming Wang, Zhengwen He, Tao Sun, Yulei Wang, Mengqian Huang, Rong Zhang, Feng Chen, Wenbin Li   +16 more
wiley   +1 more source

Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets. [PDF]

MedComm (2020)
Mao S, Qiao R, Wang Q, Shen L, Li D, Huo X, Wang J, Liu K, Chen W, Zhu T, Zhang B, Leng S, Bai Y.   +12 more
europepmc   +1 more source

Proceedings: Psychological and social impact of progressive neurological disease with special reference to the comiciliary medical, nursing, and social services. [PDF]

, 1974
Barbara C. Stevens
openalex   +1 more source

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin, Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoglu, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard Jr, the MG‐001 Study Group   +10 more
wiley   +1 more source

Inductive and Transfer Learning-Based Hybrid Model Techniques for Accurate and Automated Diagnosis of Neurological Diseases. [PDF]

Brain Behav
Pandey SK, Rathore YK, Mehra S, Sinha A, Kumar TR, Kumar A, Janghel RR, Lasisi A, Naveed QN, Reza MS.   +9 more
europepmc   +1 more source

STCDB4ND: a signal transduction classification database for neurological diseases. [PDF]

Database (Oxford)
Gong B, Li S, Chen Y, Liu L, Hofestädt R, Chen M.   +5 more
europepmc   +1 more source

Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases. [PDF]

Front Pharmacol
Bi S, Liu S, Zhu K, Gao D, Chen L, Yu C, Liang G.   +6 more
europepmc   +1 more source

Treatment of Neuromuscular Diseases Advences in Neurology Volume 17 [PDF]

, 1978
J. A. Simpson
openalex   +1 more source

Response to: Clinical Imaging Features of Sporadic and Genetic Frontotemporal Lobar Degeneration TDP‐43 A and B

Annals of Clinical and Translational Neurology, EarlyView.
Sergi Borrego‐Écija, Cèlia Cruz‐Escalera, Agnes Perez‐Millán, Jordi Juncà‐Parellà   +3 more
wiley   +1 more source

Practice Recommendations for Genetic Testing of Ataxias

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Over the past decade, significant advances in genetic testing for ataxia have improved diagnostic accuracy, informed clinical trial eligibility, guided treatment decisions, and enabled cascade testing of at‐risk relatives. While guidance exists for other neurogenetic conditions, there are no standardized guidelines on genetic ...
Sharan R. Srinivasan, Amy D. Mook, Michelle Rochman, Jin Yun Helen Chen, Weiyi Mu, George R. Wilmot, Liana S. Rosenthal, Wendy R. Uhlmann   +7 more
wiley   +1 more source